Nutritional Therapy Enriched With Omega-3 in Patients With Lung Resection

NCT06531460 · tracked via the Priya Life Science Mexico tracker

Sponsor

National Institute of Respiratory Diseases, Mexico

Phase

Not applicable

Started

2024-07-25

Last updated

2024-08-01

Condition(s) studied

Lung CancerSurgery

Investigational drug(s) / intervention(s)

Fish oil enteral supplementationFish oil oral supplementationEnteral nutrition without fish oilOral nutritional supplement without fish oil

Fish oil enteral supplementation: Omega-3 (4.2 g), administered through an enteral feeding tube, three days before surgery

Fish oil oral supplementation: Omega-3 (4.2 g), orally administered enriched nutritional formula, drinking at home three days before surgery

Enteral nutrition without fish oil: Enteral formula without omega-3 administered through an enteral feeding tube, three days before surgery

Oral nutritional supplement without fish oil: Oral nutritional supplement without omega-3 orally administered, drinking at home three days before surgery

Study summary

The aim of this study is to analyze the effect of enriched formula with omega-3 in the 30-day incidence infection and inflammatory response following lung resection surgery in lung cancer patients.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Lung cancer diagnosis * Elective surgery for lung resection schedule at least four days before surgery * Signed informed consent. Exclusion Criteria: * Acute or chronic organ failure as hepatic or renal insufficiency * Patients with fish-allergy * History of any surgery within 3 months * Immunocompromised patients

Primary outcome measure(s)

30-day incidence infection — 30-day incidence infection following lung resection in lung cancer patients.
Incidence of infectious complications after surgery diagnosed using any of these criteria: Infection of surgery wound confirmed by culture Infection confirmed by blood culture Pneumonia developed after surgery confirmed by chest x Ray.

Trial sites (1)

Facility	City	Region	Status
National Institute of Respiratory Diseases	Mexico City	Mexico	Recruiting

More National Institute of Respiratory Diseases, Mexico trials in Mexico

Nutritional Therapy in Patients With Post-extubation Dysphagia Recruiting

Other trials for the same condition

Impact of Fat-free Mass in the Carboplatin Calculated Dose and Chemotherapeutic Toxicity in Patients With Advanced NSCLC Recruiting

Lung Cancer Screening Program in Mexico Recruiting

EMUs: Enhanced Monitoring Using Sensors After Surgery Recruiting

Scale of Therapeutic Adherence to Respiratory Rahabilitation for Lung Cancer Recruiting

Oscillating Positive Expiratory Pressure Therapy for Patients With Thoracic Neoplasms Undergoing Chest Surgery Active, not recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06531460 on ClinicalTrials.gov ↗ ← All trials in Mexico